These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 33599960
1. Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum. Eichenfield LF, Siegfried E, Kwong P, McBride M, Rieger J, Glover D, Willson C, Davidson M, Burnett P, Olivadoti M. Am J Clin Dermatol; 2021 Mar; 22(2):257-265. PubMed ID: 33599960 [Abstract] [Full Text] [Related]
2. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials. Eichenfield LF, McFalda W, Brabec B, Siegfried E, Kwong P, McBride M, Rieger J, Willson C, Davidson M, Burnett P. JAMA Dermatol; 2020 Dec 01; 156(12):1315-1323. PubMed ID: 32965495 [Abstract] [Full Text] [Related]
6. Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital Warts. Guenthner S, McFalda W, Tate M, Eads K, Rieger J, Glover DK, Willson C, Rumney P, Rosen T, Andres J, Olivadoti M. Am J Clin Dermatol; 2021 Nov 01; 22(6):867-875. PubMed ID: 34515985 [Abstract] [Full Text] [Related]
10. Case report: Molluscum contagiosum. Toxic shock syndrome following cantharidin treatment. Langley JM, Soder CM, Schlievert PM, Murray S. Can Fam Physician; 2003 Jul 01; 49():887-9. PubMed ID: 12901485 [No Abstract] [Full Text] [Related]
11. Beetle juice: a guide for the use of cantharidin in the treatment of molluscum contagiosum. Moye V, Cathcart S, Burkhart CN, Morrell DS. Dermatol Ther; 2013 Jul 01; 26(6):445-51. PubMed ID: 24552407 [Abstract] [Full Text] [Related]
12. COVE-1: A Phase 2, Open-Label Study to Evaluate Efficacy and Safety and the Optimal Regimen of VP-102, a Proprietary Drug-Device Product Containing Topical Cantharidin (0.7% w/v) Under Occlusion for the Treatment of Common Warts. Guenthner S, McFalda W, Kwong P, Eads K, McCafferty M, Rieger J, Glover DK, Willson C, Burnett P, Olivadoti M. Dermatol Ther (Heidelb); 2021 Oct 01; 11(5):1623-1634. PubMed ID: 34286459 [Abstract] [Full Text] [Related]
13. Efficacy and tolerability of an investigational nitric oxide-releasing topical gel in patients with molluscum contagiosum: A randomized clinical trial. Hebert AA, Siegfried EC, Durham T, de León EN, Reams T, Messersmith E, Maeda-Chubachi T. J Am Acad Dermatol; 2020 Apr 01; 82(4):887-894. PubMed ID: 31586600 [Abstract] [Full Text] [Related]
19. Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis. Paller AS, Green LJ, Silverberg N, Stripling S, Cartwright M, Enloe C, Wells N, Kowalewski EK, Maeda-Chubachi T. Pediatr Dermatol; 2024 Apr 01; 41(3):438-444. PubMed ID: 38413239 [Abstract] [Full Text] [Related]
20. Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial. Coloe Dosal J, Stewart PW, Lin JA, Williams CS, Morrell DS. Pediatr Dermatol; 2014 Apr 01; 31(4):440-9. PubMed ID: 22897595 [Abstract] [Full Text] [Related] Page: [Next] [New Search]